Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

22nd Century Group Inc (XXII)

22nd Century Group Inc (XXII)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 333,262
  • Shares Outstanding, K 138,859
  • Annual Sales, $ 25,830 K
  • Annual Income, $ -26,560 K
  • 60-Month Beta 1.60
  • Price/Sales 11.65
  • Price/Cash Flow N/A
  • Price/Book 6.85
Trade XXII with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.15
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/11/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-2111 Cigarettes

    Tobacco

Options Overview

Details
  • Implied Volatility 204.86%
  • Historical Volatility 129.94%
  • IV Percentile 85%
  • IV Rank 41.01%
  • IV High 372.79% on 07/24/20
  • IV Low 88.11% on 05/20/20
  • Put/Call Vol Ratio 0.05
  • Today's Volume 2,671
  • Volume Avg (30-Day) 7,776
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 61,744
  • Open Int (30-Day) 58,696

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.03
  • Number of Estimates 1
  • High Estimate -0.03
  • Low Estimate -0.03
  • Prior Year -0.05
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.86 +29.03%
on 03/05/21
4.66 -48.50%
on 02/22/21
-0.61 (-20.27%)
since 02/05/21
3-Month
1.54 +55.84%
on 12/08/20
4.66 -48.50%
on 02/22/21
+0.71 (+42.01%)
since 12/04/20
52-Week
0.55 +336.36%
on 09/09/20
4.66 -48.50%
on 02/22/21
+1.58 (+191.09%)
since 03/05/20

Most Recent Stories

More News
22nd Century Group to Participate in Investor Conferences in March 2021

22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today announced...

XXII : 2.40 (+10.09%)
Will 22nd Century Group (XXII) Report Negative Earnings Next Week? What You Should Know

22nd Century (XXII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

XXII : 2.40 (+10.09%)
22nd Century Group Receives $8.1 Million from Cash Exercise of Outstanding Warrants

22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today announced...

XXII : 2.40 (+10.09%)
22nd Century Group Secures Exclusive Agreement with CannaMetrix to Accelerate Commercialization of New, Disruptive Hemp/Cannabis Plant Lines and Intellectual Property

22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced...

XXII : 2.40 (+10.09%)
22nd Century Group to Host Webcast to Discuss Fourth Quarter and Full-Year 2020 Results

22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, will host...

XXII : 2.40 (+10.09%)
22nd Century Group Provides Business Update Letter from CEO

22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today...

XXII : 2.40 (+10.09%)
22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with Commercially Valuable Traits

22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced...

XXII : 2.40 (+10.09%)
This May Be One of the Safer Alternatives to Tobacco and Nicotine

While the tobacco industry is often frowned upon, it’s also been kind to investors. In fact, ...

TOBAF : 3.3700 (-6.39%)
RLX : 16.09 (-3.25%)
UVV : 53.45 (+2.91%)
PM : 86.16 (+1.83%)
XXII : 2.40 (+10.09%)
PM.CN : 0.540 (-3.57%)
TAAT.CN : 4.340 (-4.62%)
22nd Century Group to Relocate Headquarters to Buffalo's Thriving Larkinville District

22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced...

XXII : 2.40 (+10.09%)
$ 3.35 Billion Growth in Global Industrial Hemp Market During 2020-2024 | Featuring Key Vendors Including 22nd Century Group Inc., Aurora Cannabis Inc., and Bombay Hemp Company Pvt. Ltd. | Technavio

Technavio announces the release of its latest report on the industrial hemp market. The market is segmented by application (textiles, hemp-based CBD, food and supplements, personal care, and others) and...

XXII : 2.40 (+10.09%)
ACB.TO : 12.15 (-2.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products...

See More

Key Turning Points

3rd Resistance Point 3.12
2nd Resistance Point 2.76
1st Resistance Point 2.58
Last Price 2.40
1st Support Level 2.04
2nd Support Level 1.68
3rd Support Level 1.50

See More

52-Week High 4.66
Fibonacci 61.8% 3.09
Fibonacci 50% 2.61
Last Price 2.40
Fibonacci 38.2% 2.12
52-Week Low 0.55

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar